Thrombocytopenia Clinical Trials in Shanghai, Shanghai Municipality
7 recruitingShanghai, Shanghai Municipality, China
Showing 1–7 of 7 trials
Recruiting
Phase 3
The Phase III Clinical Study of Herombopag for the Treatment of Thrombocytopenia in Chronic Liver Disease Patients Undergoing Elective Invasive Surgery
Thrombocytopenia in Chronic Liver Disease Patients Undergoing Elective Invasive Surgery
Jiangsu HengRui Medicine Co., Ltd.101 enrolled1 locationNCT06507436
Recruiting
Phase 2
Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia
ThrombocytopeniaConnective Tissue Diseases
Beijing Hospital296 enrolled23 locationsNCT05998759
Recruiting
Not Applicable
The Efficacy and Safety of HCQ Plus Pred in ANA Positive ITP
Immune Thrombocytopenia With Positive ANA Antibodies
Yunfeng Cheng129 enrolled7 locationsNCT06479304
Recruiting
Not Applicable
The Efficacy and Safety of HCQ Plus DEX in ANA Positive ITP
Immune Thrombocytopenia With Positive ANA Antibodies
Yunfeng Cheng129 enrolled7 locationsNCT06479317
Recruiting
Not Applicable
The Efficacy and Safety of HCQ Plus TPO-RA in ANA Positive ITP
Immune Thrombocytopenia With Positive ANA Antibodies
Yunfeng Cheng126 enrolled7 locationsNCT06479291
Recruiting
Phase 3
Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia
Chronic Primary Immune Thrombocytopenia (ITP)
Beijing InnoCare Pharma Tech Co., Ltd.195 enrolled45 locationsNCT06004856
Recruiting
Phase 2Phase 3
The Effect of REcombinant Human Thrombopoietin (rhTPO) on Sepsis Patients With aCUte Severe thrombocytopEnia
SepsisThrombocytopenia
Ruilan Wang200 enrolled1 locationNCT02707497